Zinc supplementation stimulates tetanus antibody formation and soluble interleukin-2 receptor levels in chronic hemodialysis patients

[1]  H. Reis,et al.  Einfluß einer Zinksubstitution auf Lymphozytensubsets und zelluläre Immunfunktionen bei Hämodialysepatienten , 1991, Klinische Wochenschrift.

[2]  K. -. Meyer zum Büschenfelde,et al.  Sekundärer Immundefekt bei Niereninsuffizienz am Beispiel der Hepatitis B-Impfung , 1988, Klinische Wochenschrift.

[3]  W. Kuhlmann,et al.  Tetanusimpfschutz und Vermeidung von Nebenreaktionen bei Auffrischimpfungen , 1992 .

[4]  A. Guérin,et al.  Response to vaccination against tetanus in chronic haemodialysed patients. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  L. Gastaldi,et al.  Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. , 1991, Nephron.

[6]  S. Meuer,et al.  Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. , 1990, Kidney international.

[7]  S. Shiozawa,et al.  Role of Zinc in Interleukin 2 (IL‐2)‐Mediated T‐Cell Activation , 1990, Scandinavian journal of immunology.

[8]  A. Schreiber,et al.  Impaired Function of Macrophage Fcγ Receptors in End-Stage Renal Disease , 1990 .

[9]  S. Meuer,et al.  Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation. , 1990, Nephron.

[10]  A. Schreiber,et al.  Impaired function of macrophage Fc gamma receptors in end-stage renal disease. , 1990, The New England journal of medicine.

[11]  G. Asmus,et al.  Soluble interleukin 2 receptor and tissue polypeptide antigen serum concentrations in end-stage renal failure. , 1990, Nephron.

[12]  H. Müller,et al.  [Tetanus prophylactic inoculation--the indications and contraindications]. , 2008, Deutsche medizinische Wochenschrift.

[13]  L. Hinks,et al.  Zinc Absorption in Haemodialysis Patients , 1988, Annals of clinical biochemistry.

[14]  L. Hinks,et al.  Reduced Leucocyte Zinc and Albumin-Bound Zinc in Blood of Haemodialysis Patients , 1987, Annals of clinical biochemistry.

[15]  L. Chatenoud,et al.  Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Meyer zum Büschenfelde,et al.  Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. , 1986, Kidney international.

[17]  P. Fraker,et al.  Interrelationships between zinc and immune function. , 1986, Federation proceedings.

[18]  P. Lepší,et al.  Renal excretion of Zn in patients with chronic renal insufficiency , 1986 .

[19]  E. Ebert,et al.  T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation. , 1986, Diagnostic immunology.

[20]  N. Muirhead,et al.  Zinc metabolism in patients on maintenance hemodialysis. , 1986, American journal of nephrology.

[21]  M. Golub,et al.  Studies of marginal zinc deprivation in rhesus monkeys: infant behavior. , 1985, The American journal of clinical nutrition.

[22]  D. Nelson,et al.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.

[23]  A. Cheung,et al.  Studies of marginal zinc deprivation in rhesus monkeys: VI. Influence on the immunohematology of infants in the first year. , 1985, The American journal of clinical nutrition.

[24]  D. Grekas,et al.  Effect of zinc treatment on cell mediated immunity of chronic renal failure patients. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

[25]  R. Winchurch,et al.  Supplemental zinc restores antibody formation in cultures of aged spleen cells. , 1984, Journal of immunology.

[26]  C. McClain,et al.  Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. , 1983, The Journal of laboratory and clinical medicine.

[27]  A. Prasad,et al.  Zinc deficiency: a reversible complication of uremia. , 1982, The American journal of clinical nutrition.

[28]  A. Prasad,et al.  Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients. , 1982, Kidney international.

[29]  P. Fraker,et al.  Delayed type hypersensitivity in zinc deficient adult mice: impairment and restoration of responsivity to dinitrofluorobenzene. , 1982, The Journal of nutrition.

[30]  G. Schechter,et al.  The effect of zinc on cellular immunity in chronic uremia. , 1981, The American journal of clinical nutrition.

[31]  A. Prasad,et al.  Improvement of uremic hypogeusia by zinc: a double-blind study. , 1980, The American journal of clinical nutrition.

[32]  C. Cunningham-Rundles,et al.  Zinc-induced activation of human B lymphocytes. , 1980, Clinical immunology and immunopathology.

[33]  P. Fraker,et al.  The effect of restricted dietary intake on the antibody mediated response of the zinc deficient A/J mouse. , 1978, The Journal of nutrition.